Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cance... (ycle of weekly Marqibo treatment. Safet...)

HOME >> MEDICINE >> TECHNOLOGY

Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound

Date:3/2/2009

ycle of weekly Marqibo treatment. Safety was assessed in the context of efficacy defined as the achievement of a complete response with or without full blood count recovery.

Susan O'Brien, M.D., professor in the leukemia department at the University of Texas MD Anderson Cancer Center in Houston, and rALLy study lead investigator, said, "Clinical results from rALLy, as well as in previous ALL trials, suggest that Marqibo could offer a unique salvage therapy for relapsed ALL and therapeutic advantage over standard vincristine-containing chemotherapy in patients with lymphoid malignancies."

The primary objective of the rALLy study is to assess the efficacy and safety of single-agent, weekly Marqibo 2.25 mg/m2 with dosing based on actual body surface area without the dose capping applied to standard vincristine. Secondary objectives include evaluation of safety, response duration, and overall survival. The patient population is defined as Philadelphia chromosome- negative adult patients in second relapse, or those patients who relapsed following two lines of anti-leukemia chemotherapy, including those who have previously undergone stem cell transplantation. The rALLy trial is currently being conducted at thirty-one clinical sites in the U.S., Canada, Germany, Israel and the United Kingdom.

Hana Biosciences has received orphan drug and fast track designations for Marqibo for the treatment of adult ALL from the U.S. Food and Drug Administration. Marqibo has also received orphan drug designation from the European Medicines Evaluation Agency in adult ALL.

About Marqibo(R) (vincristine sulfate liposomes injection)

Marqibo is a novel, targeted, Optisomal(TM) formulation of vincristine, a widely-used chemotherapy, which has shown promising anti-cancer activity in patients with ALL, non-Hodgkin's lymphoma, Hodgkin's disease, and melanoma in several clinical trials. Vincri
'/>"/>

SOURCE Hana Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions

Post Your Comments:

(Date:5/23/2013)... , May 23, 2013 Hearing health affects ... feel younger, and remain socially and professionally engaged, he should ... the overriding message that the Better Hearing Institute ... of National Men,s Health Week , which leads up ... Week runs from June 10 through June 16. ...

(Date:5/23/2013)... , May 23, 2013 More than half ... not benefit from chemotherapy and still have excellent outcomes. ... of one of the largest sources of online consumer ... and interactive Facebook page provide recently diagnosed women with ... safely avoid chemotherapy. "We anticipate these innovative ...

(Date:5/23/2013)... BEDFORD, Mass. , May 23, 2013 /PRNewswire/ ... HOLX ), a leading developer, manufacturer and ... surgical products, with an emphasis on serving the ... first large-scale observational study in a U.S. clinical ... mammography technology (breast tomosynthesis) with conventional 2D mammography ...

Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4

[0] Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises [0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions [0] First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection

... Merger Agreement with Tonsun International Company Limited,... -- SHENZHEN, China, Nov. 1, 2010 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; ...

... NICOSIA, Cyprus, Nov. 1, 2010 MedWOW.com, the global online ... the addition of its newest user-oriented tool: a Medical ... difficult and costly process to look for replacement parts for ... to streamline the search for buyers unable to find the ...

Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited MedWOW Adds Parts Finder Service and Enhances Business Model

(Date:5/23/2013)... (PRWEB) May 23, 2013 Da Vinci ... in a trial in Washington State May 23, according ... clients in surgical robot lawsuits , expresses disappointment ... da Vinci lawsuits to not read a single verdict ... case (Estate of Fred E. Taylor v. Intuitive Surgical ...

(Date:5/23/2013)... , , THURSDAY, May 23 (HealthDay News) -- Glucosamine supplements ... and knee osteoarthritis may have an unexpected side effect: ... new study of older adults suggests. Glaucoma ... (IOP) or pressure inside the eye. Left untreated, glaucoma ... In the new study of 17 people, ...

(Date:5/23/2013)... -- People who eat at fast-food restaurants are consuming ... are the worst offenders, a new study found. ... by as much as 34 percent, parents of school-age ... by as much as 20 percent," study lead researcher, ... the Robert Wood Johnson Foundation, which helped fund the ...

(Date:5/23/2013)... 23, 2013)Don,t doubt it when a woman harried by ... things. A new study published online in Menopause ... (NAMS), helps confirm with objective tests that what these ... the past, some studies showed that hot flashes were ... showed that, even though there was a relationship between ...

(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... announcement (PSA) campaign that empowers parents to talk to ... dangers of underage drinking, was launched today by the ... , The kickoff occurred in conjunction with SAMHSA’s 2013 ... awareness of, and action around, substance abuse and mental ...

Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2 Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2 Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3 Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2 Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2

[0] Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial [0] Glucosamine Supplements Tied to Risk of Eye Condition [0] How Many Calories in Your Fast-Food Meal? Guess Again [0] It's not your imagination: Memory gets muddled at menopause [0] New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking

... ... ... leading,floral service offering only hand-arranged, hand-delivered floral,arrangements by local Teleflora ... To Cancer (SU2C) a new initiative to raise,philanthropic dollars for ...

... Plan Provider,s Payment ... Improves Operational Efficiency, CAMBRIDGE, England and SAN ... AU. or AU.L), a global leader in,infrastructure software ... (GVS) has selected Cardiff,s information capture and,business process ...

... students across 70 colleges and universities who completed a ... episode of suicidal thinking at some point in their ... seriously considered attempting suicide and more than 5 percent ... their lifetime. , Presenting Sunday at the 116th Annual ...

... A second Phase I AIDS vaccine clinical trial ... Medical Research, the National AIDS Control Organization and the ... trial of an MVA-based AIDS vaccine candidate (TBC-M4), which ... had acceptable levels of safety and was well tolerated. ...

... in Bad Faith, LOS ANGELES, Aug. 15 ... Daughters of Charity,Health System are planning a one-day strike ... Healthcare Workers-West have been,bargaining a new contract with the ... any economic proposals, and is attempting to,take away the ...

... Aug. 15 Following is a,statement of Betsy ... Horizon Blue Cross Blue Shield today submitted an ... insurer to a publicly traded for-profit,company., All ... of such a,conversion. With approximately 2.9 million members, ...

Cached Medicine News:Health News:Teleflora and Stand Up To Cancer Join Forces 2 Health News:Teleflora and Stand Up To Cancer Join Forces 3 Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 2 Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 3 Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 4 Health News:Suicidal thoughts among college students more common than expected 2 Health News:Suicidal thoughts among college students more common than expected 3 Health News:India continues to progress in AIDS vaccine development efforts 2 Health News:India continues to progress in AIDS vaccine development efforts 3 Health News:NJHA Raises Questions Regarding Horizon's Proposal to Convert to For-Profit Health Insurer 2

Teleflora and Stand Up To Cancer Join Forces General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services Suicidal thoughts among college students more common than expected India continues to progress in AIDS vaccine development efforts UHW Healthcare Workers to Strike at Five Hospitals NJHA Raises Questions Regarding Horizon's Proposal to Convert to For-Profit Health Insurer

... XL Advantage delivers higher magnification for advanced ... true image, even at the highest magnification. ... clarity and precise color rendition is ideal ... an anti-reflective coating produce a superior image. ...

... doublet objective and high power negative lens ... The true benefit of this system is ... clarity is made possible due to a ... aluminum bar and individual interpupillary adjustment provides ...

... Keeler Galilean loupes are ideal for ... increased magnification and a large field ... are laser aligned, lightweight and comfortable ... working distance and superior depth of ...

23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov...

Medicine Products:

XL Advantage 3.5x @ 46cm working distance SuperVu 3.0x Galilean system SuperVu Galilean System Gills-Welsh Irrigating-Aspirating Cannula